New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 16, 2014
09:12 EDTBBY, CSX, UNH, AMGN, ILMN, SRPT, NUS, BLK, APO, CEC, SCHW, YHOO, JCP, C, HPQ, AMRNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Charles Schwab (SCHW), up 3%... BlackRock (BLK), up 1.5%. ALSO HIGHER: CEC Entertainment (CEC), up 13% after acquired by Apollo (APO) affiliate for $54 per share... HP (HPQ), up 2% after upgraded at BofA Merrill Lynch... Sarepta Therapeutics (SRPT), up 16% after announcing that data from a study of eteplirsen demonstrates continued stability in walking test... Illumina (ILMN), up 4.8% after in agreement with Amgen (AMGN) to develop oncology companion diagnostic test. DOWN AFTER EARNINGS: Citigroup (C), down 2.6%... CSX (CSX), down 6%.... UnitedHealth (UNH), down 0.5%. ALSO LOWER: Best Buy (BBY), down 30% after reporting domestic Holiday same-store sales fell 0.9%... Yahoo (YHOO), down 2% after COO Henrique de Castro to leave company effective January 16 after reportedly clashing with CEO Mayer... J.C. Penney (JCP), down 3.9% after announcing plans to close 33 underperforming stores and cut 2K jobs... after reporting earnings and revenue that just slightly missed estimates... Nu Skin (NUS), down 16.3% after responding to People's Daily article that called it a "pyramid scheme"... Amarin (AMRN), down 9.6% after the FDA delayed its ANCHOR SPA appeal, shares downgraded at MKM Partners.
News For BBY;HPQ;C;JCP;YHOO;SCHW;CEC;APO;BLK;NUS;SRPT;ILMN;AMGN;UNH;CSX;AMRN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>
October 8, 2014
10:33 EDTJCPJ.C. Penney says seeing "significant" shift to mobile
Subscribe for More Information
10:25 EDTJCPJ.C. Penney says home is $750M growth opportunity
Subscribe for More Information
10:20 EDTAMGNAmgen biosimilar franchise underappreciated, says Piper Jaffray
After Amgen announced positive Phase 3 results for its biosimilar Humira in psoriasis, Piper Jaffray said it believes that Amgen's overall pipeline is underappreciated since the company's biosimilar franchise is generally not included in consensus estimates. The firm views Amgen as a top large cap picks and reiterate its Overweight rating on the stock.
10:06 EDTCSXStephens transportation analysts hold an analyst/industry conference call
Subscribe for More Information
09:53 EDTHPQHP, EMC still doing due diligence on potential deal, CNBC reports
Subscribe for More Information
09:49 EDTHPQHP, EMC merger unlikely but still possible, CNBC's Faber says
09:48 EDTHPQHP, EMC still doing work on potential deal, CNBC reports
Subscribe for More Information
09:20 EDTJCPJ.C. Penney says will expand Disney stops in stores to 680 from 500
09:20 EDTJCPJ.C. Penney CEOsays will open more Sephora shops in store
Subscribe for More Information
09:20 EDTJCPOn The Fly: Pre-market Movers
Subscribe for More Information
09:16 EDTAMGNAmgen's ABP 501 for psoriasis shows positive Phase 3 results
Subscribe for More Information
08:18 EDTJCPJ.C. Penney CEO Ullman says customers remain cautious
Subscribe for More Information
08:06 EDTCAstoria Financial appoints Hugh J. Donlon as Chief Lending Officer
Subscribe for More Information
08:00 EDTBLKBlackRock volatility increases into Q3 and guidance
Subscribe for More Information
07:19 EDTAMGNCBI to hold a conference
Subscribe for More Information
07:13 EDTCBank dealers agree to revised derivatives rules, FT reports
Subscribe for More Information
07:11 EDTAMGNEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
07:08 EDTAPOApollo Global coverage assumed with an Outperform at Credit Suisse
Target $32.
06:19 EDTYHOOYahoo lays off 400 employees in India, WSJ reports
Subscribe for More Information
06:13 EDTHPQNon-Apple notebook, tablet demand to be weak till 2Q15, DigiTimes reports
Demand for non-Apple (AAPL) notebooks and tablets may remain weak until the second quarter of 2015, reports DigiTimes. Citing Taiwan makers, the pressure due to booming sales from Apple products may decrease sales until Microsoft (MSFT) launches Windows 10 next year. Demand for Samsung (SSNLF), Sony (SNE) , And HTC smartphones have also dropped worldwide recently. Reference Link
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use